Trial NCT00197145

View at ClinicalTrials.gov 
Org. Study IDs: CCR102709

Last trial update was posted on 2018-11-02

MeSH Interventions

Aplaviroc

MeSH Conditions

Acquired Immunodeficiency Syndrome HIV Infections

Other Conditions

Infection, Human Immunodeficiency Virus I

Stopping Reasons

N/A

Limitations And Caveats

Study was early terminated prior to the completion of enrollment due to treatment-emergent hepatotoxicity that occurred among some participants receiving APL.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID